MRNA Latest Headlines

Balanced Legal and Fundamental Uncertainties Justify Maintaining a Hold on Moderna

at www.tipranks.com (Mon, 2-Feb 9:26 PM)

Moderna’s CMV Vaccine Extension Study Reaches Completion, Setting the Stage for Next Growth Catalyst

at www.tipranks.com (Mon, 2-Feb 11:30 AM)

SPY ETF Daily Update, 2/2/2026

at www.tipranks.com (Mon, 2-Feb 8:26 AM)

Notable healthcare headlines for the week: UnitedHealth, Novo Nordisk, and Thermo Fisher in focus

at seekingalpha.com (Sun, 1-Feb 9:05 AM)

SNDK, MU, CRM: January’s Best and Worst-Performing Stocks

at www.tipranks.com (Sat, 31-Jan 4:00 PM)

Moderna Stock Slips As Ambitious Cancer Trials Drag On

at www.tipranks.com (Sat, 31-Jan 9:01 AM)

Leadership Overhaul at Moderna: Appointment of Dr. David Berman Signals Focus on Oncology Innovation

Market Chameleon (Fri, 30-Jan 7:39 AM)

SNDK, MU, CRM: January’s Best and Worst Performing Stocks

at www.tipranks.com (Fri, 30-Jan 4:23 PM)

Moderna announces departure of medical chief

at seekingalpha.com (Fri, 30-Jan 12:13 PM)

Piper Sandler Keeps Their Buy Rating on Moderna (MRNA)

at www.tipranks.com (Fri, 30-Jan 7:26 AM)

Vanguard S&P 500 ETF (VOO) Daily Update, 1/30/2026

at www.tipranks.com (Fri, 30-Jan 7:20 AM)

SPY ETF Daily Update, 1/30/2026

at www.tipranks.com (Fri, 30-Jan 6:37 AM)

Citi Sticks to Its Hold Rating for Moderna (MRNA)

at www.tipranks.com (Fri, 30-Jan 6:26 AM)

Moderna Schedules Q4 2025 Earnings Call for February 13, 2026—Investors Eye Updates on mRNA Pipeline

Market Chameleon (Mon, 26-Jan 8:40 AM)

How this MRNA Bull Put Spread Could Make 20% in 6 Days

Market Chameleon (Thu, 22-Jan 12:51 PM)

MRNA Iron Condor Spread Can Make 71% in Next 6 Days

Market Chameleon (Thu, 22-Jan 11:32 AM)

MRNA & Merck Reveal 49% Reduction in Cancer Recurrence Risk—Five-Year Melanoma Data Reinforce Long-Term Potential

Market Chameleon (Tue, 20-Jan 7:13 AM)

Moderna Seeks Global Approvals for mRNA Flu Vaccine as Phase 3 Data Show Consistent Efficacy in Older Adults

Market Chameleon (Mon, 5-Jan 9:07 AM)

Moderna Targets 10% Revenue Growth by 2026 with Expanded Vaccine Pipeline and Streamlined Operations

Market Chameleon (Thu, 20-Nov 7:38 AM)

Moderna Set to Highlight mRNA Innovation at Piper Sandler Healthcare Conference—All Eyes on December 2 Event

Market Chameleon (Tue, 18-Nov 8:01 AM)

Moderna Lowers Costs and Narrows Revenue Outlook While Advancing Late-Stage Vaccine Pipeline

Market Chameleon (Thu, 6-Nov 8:04 AM)

Moderna Launches First Patient Study of Multiplexed mRNA T-Cell Engager for Multiple Myeloma

Market Chameleon (Mon, 3-Nov 7:14 AM)